SLC25A22 and colonic neoplasm: In KRAS mutant colon cancer cells, SLC25A22 promotes the accumulation of succinic acid, a metabolite of glutamine in the tricarboxylic acid cycle, which further increases the local methylation degree of DNA and then promotes the activation of Wnt signaling pathway.